The Federal Trade Commission proposed a rule that will prohibit companies from including noncompete clauses in employment agreements—a move many experts believe "will make the healthcare labor market more fluid and competitive."
FDA on Friday issued accelerated approval to lecanemab, an experimental Alzheimer's drug developed by Eisai and Biogen, for certain Alzheimer's patients. But many experts say that until the drug is covered by Medicare, its high price tag will prevent many patients from accessing it.
As the new year begins, many people have chosen to abstain from alcohol and participate in "Dry January." Writing in Harvard Public Health, Christine Mehta interviews Aaron Carroll about the potential benefits and risks of alcohol and whether a "Damp January" may be more appropriate for some people.
Writing for the Harvard Business Review, Nicholas Bloom, Jose Maria Barrero, Steven Davis, Brent Meyer, and Emil Mihaylov outline survey findings that identify the key differences between managers' and employees' perspectives on remote work. See the key differences in our interactive chart.
Over the last few years, more and more orthopedic practices have been sold to private equity firms—leading some critics to express concerns about a potential increase in costs and a lower quality of care, Harris Meyer writes for Kaiser Health News.